Cephalalgia · 2003 · 39 citations · 23 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyPain MedicinePharmacovigilanceHeadache ManagementMedication UseMedication Use EvaluationMigraine PharmacotherapyPharmacoepidemiologyHeadache ProphylaxisMigraine ProphylaxisPreventive Migraine TherapyPreventive Migraine TreatmentProphylactic TreatmentTherapeutic Efficacy AssessmentTreatment Regimen ModificationTriptan Therapy
This study aims to investigate usage patterns of specific migraine prophylactic medications in ergotamine and triptan patients commencing this treatment for the first time during 1 January 1992 until 31 December 1998. Usage patterns of specific migraine prophylactic drugs were evaluated for each patient by accessing data from a large prescription database and were characterized as continued, switch or stop use during the patient observation period. Several patient and medication-related factors were explored in order to identify a possible relationship with the specific usage pattern defined. Approximately 75% of the study population (n = 729) had terminated (stop or switch) prophylactic treatment after 1 year. Age < 40 years (relative risk (RR) 1.9; 95% confidence interval (CI) 1.2-3.2) and the concomitant use of non-steroidal anti-inflammatory drugs (RR 3.2; 95% CI 1.2-5.5) or specific abortive migraine drugs resulted in a faster onset of treatment modification (switch). Overall, migraine prophylactic treatment is used for a relatively short period, probably attributable to the common limitations associated with migraine prophylaxis, such as poor compliance and/or limited therapeutic efficacy. Patterns of use can be influenced by a variety of factors, including age, type of prescriber and certain co-medication. Patient interview studies are required to clarify these issues further.
23
Naomi Breslau, Lonni Schultz, Walter F. Stewart et al. · Neurology · 2000 · 462 citations
John Edmeads, Helen Findlay, Peter Tugwell et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 1993 · 419 citations · Full text
Pharmacy, Neurology, Pharmacotherapy +15